{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:46:38Z","timestamp":1788921998993,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract\u00a0<\/jats:title><jats:p>Fatty acid\u2013binding proteins (FABPs) play a pivotal role in the metabolism of fatty acids and are expressed in a tissue-specific manner.\u00a0FABP1 is most abundantly expressed in the liver where it accounts for about 10% of the total cytosolic protein and is thought to have diagnostic utility. To comprehensively determine FABP1\u00a0expression in normal and neoplastic tissues, a tissue microarray containing 17,071 samples from 150 different tumor types and subtypes as well as 608 samples of 76 different normal tissue types was analyzed by immunohistochemistry. Among normal tissues, a strong FABP1 immunostaining was observed in hepatocytes, proximal tubuli of the kidney and epithelium of small intestine, appendix, and the colorectum. FABP1\u00a0positivity was found in 24 of 150 tumor categories, including 17 tumor categories with at least 1 strongly positive case. The highest FABP1 positivity rates were seen in colorectal adenomas (86%), in colorectal adenocarcinomas (71.1%), and in hepatocellular carcinomas (65.3%), followed by mucinous carcinoma of the ovary (34.6%), cholangiocarcinoma (21.6%), and various adenocarcinomas from the digestive tract (10\u201323%). Eleven additional entities had positivity rates between 0.2 and 6.5%. FABP1 staining was not seen in 169 primary adenocarcinomas of the lung. In colorectal cancer, reduced FABP1 expression was linked to poor-grade, right-sided tumor location, microsatellite instability (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001 each), and absence of BRAF V600E mutations (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), but unrelated to pT and pN status. FABP1 expression has considerably high tumor specificity. As FABP1 expression was virtually absent in adenocarcinomas of the lung, FABP1 immunohistochemistry might be particularly helpful to assist in the identification of metastatic colorectal or gastrointestinal adenocarcinoma to the lung.<\/jats:p>","DOI":"10.1007\/s00428-022-03394-5","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T14:03:01Z","timestamp":1660226581000},"page":"945-961","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors"],"prefix":"10.1007","volume":"481","author":[{"given":"David","family":"Dum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ocokoljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Lennartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Reiswich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"H\u00f6flmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bernreuther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lebok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Luebke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Burandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0158-4258","authenticated-orcid":false,"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till S.","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Menz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"B\u00fcscheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gorbokon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas C.","family":"Blessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Krech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"3394_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gene.2018.07.035","volume":"676","author":"M Amiri","year":"2018","unstructured":"Amiri M, Yousefnia S, Seyed Forootan F, Peymani M, Ghaedi K, Nasr Esfahani MH (2018) Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers. Gene 676:171\u2013183. https:\/\/doi.org\/10.1016\/j.gene.2018.07.035","journal-title":"Gene"},{"key":"3394_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1479-7364-5-3-170","volume":"5","author":"RL Smathers","year":"2011","unstructured":"Smathers RL, Petersen DR (2011) The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics 5:170\u2013191. https:\/\/doi.org\/10.1186\/1479-7364-5-3-170","journal-title":"Hum Genomics"},{"key":"3394_CR3","doi-asserted-by":"publisher","first-page":"32679","DOI":"10.1074\/jbc.R110.135210","volume":"285","author":"J Storch","year":"2010","unstructured":"Storch J, Thumser AE (2010) Tissue-specific functions in the fatty acid-binding protein family. J Biol Chem 285:32679\u201332683. https:\/\/doi.org\/10.1074\/jbc.R110.135210","journal-title":"J Biol Chem"},{"key":"3394_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MCO.0000000000000031","volume":"17","author":"AE Thumser","year":"2014","unstructured":"Thumser AE, Moore JB, Plant NJ (2014) Fatty acid binding proteins: tissue-specific functions in health and disease. Curr Opin Clin Nutr Metab Care 17:124\u2013129. https:\/\/doi.org\/10.1097\/MCO.0000000000000031","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3394_CR5","doi-asserted-by":"publisher","first-page":"16060","DOI":"10.1016\/S0021-9258(18)47696-X","volume":"262","author":"DA Sweetser","year":"1987","unstructured":"Sweetser DA, Birkenmeier EH, Klisak IJ, Zollman S, Sparkes RS, Mohandas T, Lusis AJ, Gordon JI (1987) The human and rodent intestinal fatty acid binding protein genes A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem 262:16060\u201316071","journal-title":"J Biol Chem"},{"key":"3394_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00231388","volume":"98","author":"L Vergani","year":"1990","unstructured":"Vergani L, Fanin M, Martinuzzi A, Galassi A, Appi A, Carrozzo R, Rosa M, Angelini C (1990) Liver fatty acid-binding protein in two cases of human lipid storage. Mol Cell Biochem 98:225\u2013230. https:\/\/doi.org\/10.1007\/BF00231388","journal-title":"Mol Cell Biochem"},{"key":"3394_CR7","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1194\/jlr.R056705","volume":"56","author":"G Wang","year":"2015","unstructured":"Wang G, Bonkovsky HL, de Lemos A, Burczynski FJ (2015) Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res 56:2238\u20132247. https:\/\/doi.org\/10.1194\/jlr.R056705","journal-title":"J Lipid Res"},{"key":"3394_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","volume":"7","author":"M Furuhashi","year":"2008","unstructured":"Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489\u2013503. https:\/\/doi.org\/10.1038\/nrd2589","journal-title":"Nat Rev Drug Discov"},{"key":"3394_CR9","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1021\/jm701192w","volume":"51","author":"S Chuang","year":"2008","unstructured":"Chuang S, Velkov T, Horne J, Porter CJ, Scanlon MJ (2008) Characterization of the drug binding specificity of rat liver fatty acid binding protein. J Med Chem 51:3755\u20133764. https:\/\/doi.org\/10.1021\/jm701192w","journal-title":"J Med Chem"},{"key":"3394_CR10","doi-asserted-by":"publisher","first-page":"109336","DOI":"10.1016\/j.cellsig.2019.06.001","volume":"62","author":"IH McKillop","year":"2019","unstructured":"McKillop IH, Girardi CA, Thompson KJ (2019) Role of fatty acid binding proteins (FABPs) in cancer development and progression. Cell Signal 62:109336. https:\/\/doi.org\/10.1016\/j.cellsig.2019.06.001","journal-title":"Cell Signal"},{"key":"3394_CR11","doi-asserted-by":"publisher","first-page":"589206","DOI":"10.3389\/fimmu.2021.589206","volume":"12","author":"CH Lee","year":"2021","unstructured":"Lee CH, Lui DTW, Lam KSL (2021) Adipocyte fatty acid-binding protein, cardiovascular diseases and mortality. Front Immunol 12:589206. https:\/\/doi.org\/10.3389\/fimmu.2021.589206","journal-title":"Front Immunol"},{"key":"3394_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.1711610113","volume":"161","author":"T Suzuki","year":"1990","unstructured":"Suzuki T, Watanabe K, Ono T (1990) Immunohistochemical demonstration of liver fatty acid-binding protein in human hepatocellular malignancies. J Pathol 161:79\u201383. https:\/\/doi.org\/10.1002\/path.1711610113","journal-title":"J Pathol"},{"key":"3394_CR13","first-page":"1321","volume":"61","author":"B Wang","year":"2014","unstructured":"Wang B, Tao X, Huang CZ, Liu JF, Ye YB, Huang AM (2014) Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma. Hepatogastroenterology 61:1321\u20131326","journal-title":"Hepatogastroenterology"},{"key":"3394_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000089417","volume":"72","author":"T Kawamura","year":"2005","unstructured":"Kawamura T, Kanno R, Fujii H, Suzuki T (2005) Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma. Pathobiology 72:233\u2013240. https:\/\/doi.org\/10.1159\/000089417","journal-title":"Pathobiology"},{"key":"3394_CR15","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/sj.bjc.6601828","volume":"90","author":"LC Lawrie","year":"2004","unstructured":"Lawrie LC, Dundas SR, Curran S, Murray GI (2004) Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer 90:1955\u20131960. https:\/\/doi.org\/10.1038\/sj.bjc.6601828","journal-title":"Br J Cancer"},{"key":"3394_CR16","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1021\/pr060644r","volume":"6","author":"H Pei","year":"2007","unstructured":"Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen L, Chen J, Zeng L, Fan J, Li X, Gong Y, Shen H (2007) Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 6:2495\u20132501. https:\/\/doi.org\/10.1021\/pr060644r","journal-title":"J Proteome Res"},{"key":"3394_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000076465","volume":"71","author":"T Hashimoto","year":"2004","unstructured":"Hashimoto T, Kusakabe T, Watanabe K, Sugino T, Fukuda T, Nashimoto A, Honma K, Sato Y, Kimura H, Fujii H, Suzuki T (2004) Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma. Pathobiology 71:115\u2013122. https:\/\/doi.org\/10.1159\/000076465","journal-title":"Pathobiology"},{"key":"3394_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/1471-2407-9-248","volume":"9","author":"A Tolle","year":"2009","unstructured":"Tolle A, Jung M, Lein M, Johannsen M, Miller K, Moch H, Jung K, Kristiansen G (2009) Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer 9:248. https:\/\/doi.org\/10.1186\/1471-2407-9-248","journal-title":"BMC Cancer"},{"key":"3394_CR19","doi-asserted-by":"publisher","unstructured":"Sharaf RN, Butte AJ, Montgomery KD, Pai R, Dudley JT, Pasricha PJ (2011) Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes BMC Gastroenterol 11:5. https:\/\/doi.org\/10.1186\/1471-230X-11-5","DOI":"10.1186\/1471-230X-11-5"},{"key":"3394_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4939-3204-7_3","volume":"1381","author":"AM Dancau","year":"2016","unstructured":"Dancau AM, Simon R, Mirlacher M, Sauter G (2016) Tissue Microarrays Methods Mol Biol 1381:53\u201365. https:\/\/doi.org\/10.1007\/978-1-4939-3204-7_3","journal-title":"Tissue Microarrays Methods Mol Biol"},{"key":"3394_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844\u2013847. https:\/\/doi.org\/10.1038\/nm0798-844","journal-title":"Nat Med"},{"key":"3394_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-60761-806-5_12","volume":"664","author":"R Simon","year":"2010","unstructured":"Simon R, Mirlacher M, Sauter G (2010) Immunohistochemical analysis of tissue microarrays. Methods Mol Biol 664:113\u2013126. https:\/\/doi.org\/10.1007\/978-1-60761-806-5_12","journal-title":"Methods Mol Biol"},{"key":"3394_CR23","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.yexmp.2022.104762","volume":"126","author":"D Dum","year":"2022","unstructured":"Dum D, Menz A, Volkel C, De Wispelaere N, Hinsch A, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, Fraune C, Moller K, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, Sauter G, Uhlig R, Wilczak W, Steurer S, Minner S, Marx AH, Simon R, Burandt E, Krech T (2022) Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Exp Mol Pathol 126:104762. https:\/\/doi.org\/10.1016\/j.yexmp.2022.104762","journal-title":"Exp Mol Pathol"},{"key":"3394_CR24","doi-asserted-by":"publisher","unstructured":"Dum D, Lennartz M, Menz A, Kluth M, Hube-Magg C, Weidemann S, Fraune C, Luebke AM, Hornsteiner L, Bernreuther C, Simon R, Clauditz TS, Sauter G, Uhlig R, Hinsch A, Kind S, Jacobsen F, Moller K, Wilczak W, Steurer S, Minner S, Burandt E, Marx AH, Krech T, Lebok P (2022) Villin expression in human tumours: a tissue microarray study on 14,398 tumours Expert Rev Mol Diagn. https:\/\/doi.org\/10.1080\/14737159.2022.2104122","DOI":"10.1080\/14737159.2022.2104122"},{"key":"3394_CR25","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0317-OA","volume-title":"SATB2 expression in human tumors: a tissue microarray study on more than 15,000 tumors Arch","author":"D Dum","year":"2022","unstructured":"Dum D, Kromm D, Lennartz M, De Wispelaere N, B\u00fcscheck F, Luebke AM, Burandt E, Menz A, Kluth M, Hube-Magg C, Hinsch A, H\u00f6flmayer D, Weidemann S, Fraune C, M\u00f6ller K, Lebok P, Sauter G, Simon R, Uhlig R, Wilczak W, Minner S, Krech R, Bernreuther C, Marx AH, Steurer S, Jacobsen F, Clauditz TS, Krech T (2022) SATB2 expression in human tumors: a tissue microarray study on more than 15,000 tumors Arch. Pathol. Lab, Med (In press)"},{"key":"3394_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nmeth.3995","volume":"13","author":"M Uhlen","year":"2016","unstructured":"Uhlen M, Bandrowski A, Carr S, Edwards A, Ellenberg J, Lundberg E, Rimm DL, Rodriguez H, Hiltke T, Snyder M, Yamamoto T (2016) A proposal for validation of antibodies. Nat Methods 13:823\u2013827. https:\/\/doi.org\/10.1038\/nmeth.3995","journal-title":"Nat Methods"},{"key":"3394_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"Consortium GT","year":"2013","unstructured":"Consortium GT (2013) The genotype-tissue expression (GTEx) project. Nat Genet 45:580\u2013585. https:\/\/doi.org\/10.1038\/ng.2653","journal-title":"Nat Genet"},{"key":"3394_CR28","doi-asserted-by":"publisher","first-page":"D752","DOI":"10.1093\/nar\/gky1099","volume":"47","author":"M Lizio","year":"2019","unstructured":"Lizio M, Abugessaisa I, Noguchi S, Kondo A, Hasegawa A, Hon CC, de Hoon M, Severin J, Oki S, Hayashizaki Y, Carninci P, Kasukawa T, Kawaji H (2019) Update of the FANTOM web resource: expansion to provide additional transcriptome atlases. Nucleic Acids Res 47:D752\u2013D758. https:\/\/doi.org\/10.1093\/nar\/gky1099","journal-title":"Nucleic Acids Res"},{"key":"3394_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","volume":"16","author":"M Lizio","year":"2015","unstructured":"Lizio M, Harshbarger J, Shimoji H, Severin J, Kasukawa T, Sahin S, Abugessaisa I, Fukuda S, Hori F, Ishikawa-Kato S, Mungall CJ, Arner E, Baillie JK, Bertin N, Bono H, de Hoon M, Diehl AD, Dimont E, Freeman TC, Fujieda K, Hide W, Kaliyaperumal R, Katayama T, Lassmann T, Meehan TF, Nishikata K, Ono H, Rehli M, Sandelin A, Schultes EA, t Hoen PA, Tatum Z, Thompson M, Toyoda T, Wright DW, Daub CO, Itoh M, Carninci P, Hayashizaki Y, Forrest AR, Kawaji H, consortium F, (2015) Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol 16:22. https:\/\/doi.org\/10.1186\/s13059-014-0560-6","journal-title":"Genome Biol"},{"key":"3394_CR30","doi-asserted-by":"publisher","unstructured":"Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, Alm T, Asplund A, Bjork L, Breckels LM, Backstrom A, Danielsson F, Fagerberg L, Fall J, Gatto L, Gnann C, Hober S, Hjelmare M, Johansson F, Lee S, Lindskog C, Mulder J, Mulvey CM, Nilsson P, Oksvold P, Rockberg J, Schutten R, Schwenk JM, Sivertsson A, Sjostedt E, Skogs M, Stadler C, Sullivan DP, Tegel H, Winsnes C, Zhang C, Zwahlen M, Mardinoglu A, Ponten F, von Feilitzen K, Lilley KS, Uhlen M, Lundberg E (2017) A subcellular map of the human proteome Science 356. https:\/\/doi.org\/10.1126\/science.aal3321","DOI":"10.1126\/science.aal3321"},{"key":"3394_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.humpath.2015.12.002","volume":"50","author":"SJ Cho","year":"2016","unstructured":"Cho SJ, Ferrell LD, Gill RM (2016) Expression of liver fatty acid binding protein in hepatocellular carcinoma. Hum Pathol 50:135\u2013139. https:\/\/doi.org\/10.1016\/j.humpath.2015.12.002","journal-title":"Hum Pathol"},{"key":"3394_CR32","doi-asserted-by":"publisher","first-page":"17541","DOI":"10.3748\/wjg.v20.i46.17541","volume":"20","author":"M Inoue","year":"2014","unstructured":"Inoue M, Takahashi Y, Fujii T, Kitagawa M, Fukusato T (2014) Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. World J Gastroenterol 20:17541\u201317551. https:\/\/doi.org\/10.3748\/wjg.v20.i46.17541","journal-title":"World J Gastroenterol"},{"key":"3394_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/PAT.0000000000000298","volume":"47","author":"H Reis","year":"2015","unstructured":"Reis H, Padden J, Ahrens M, Putter C, Bertram S, Pott LL, Reis AC, Weber F, Juntermanns B, Hoffmann AC, Eisenacher M, Schlaak JF, Canbay A, Meyer HE, Sitek B, Baba HA (2015) Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomas. Pathology 47:543\u2013550. https:\/\/doi.org\/10.1097\/PAT.0000000000000298","journal-title":"Pathology"},{"key":"3394_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(sici)1096-9098(199910)72:2<83::aid-jso8>3.0.co;2-c","volume":"72","author":"T Yamazaki","year":"1999","unstructured":"Yamazaki T, Kanda T, Sakai Y, Hatakeyama K (1999) Liver fatty acid-binding protein is a new prognostic factor for hepatic resection of colorectal cancer metastases. J Surg Oncol 72:83\u201387. https:\/\/doi.org\/10.1002\/(sici)1096-9098(199910)72:2%3c83::aid-jso8%3e3.0.co;2-c","journal-title":"J Surg Oncol"},{"key":"3394_CR35","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/hep.21743","volume":"46","author":"P Bioulac-Sage","year":"2007","unstructured":"Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, Balabaud C, Zucman-Rossi J (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740\u2013748. https:\/\/doi.org\/10.1002\/hep.21743","journal-title":"Hepatology"},{"key":"3394_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13000-016-0475-5","volume":"11","author":"E Margolskee","year":"2016","unstructured":"Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M (2016) Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis. Diagn Pathol 11:27. https:\/\/doi.org\/10.1186\/s13000-016-0475-5","journal-title":"Diagn Pathol"},{"key":"3394_CR37","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/PAS.0000000000000624","volume":"40","author":"L Liu","year":"2016","unstructured":"Liu L, Shah SS, Naini BV, French S, Wu TT, Torbenson MS, Chandan VS (2016) Immunostains used to subtype hepatic adenomas do not distinguish hepatic adenomas from hepatocellular carcinomas. Am J Surg Pathol 40:1062\u20131069. https:\/\/doi.org\/10.1097\/PAS.0000000000000624","journal-title":"Am J Surg Pathol"},{"key":"3394_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.path.2018.02.007","volume":"11","author":"M Torbenson","year":"2018","unstructured":"Torbenson M (2018) Hepatic adenomas: classification, controversies, and consensus. Surg Pathol Clin 11:351\u2013366. https:\/\/doi.org\/10.1016\/j.path.2018.02.007","journal-title":"Surg Pathol Clin"},{"key":"3394_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/modpathol.2016.170","volume":"30","author":"SM Wood","year":"2017","unstructured":"Wood SM, Gill AJ, Brodsky AS, Lu S, Friedman K, Karashchuk G, Lombardo K, Yang D, Resnick MB (2017) Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon gamma pathway. Mod Pathol 30:123\u2013133. https:\/\/doi.org\/10.1038\/modpathol.2016.170","journal-title":"Mod Pathol"},{"key":"3394_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000268406","volume":"27","author":"P Bioulac-Sage","year":"2010","unstructured":"Bioulac-Sage P, Balabaud C, Zucman-Rossi J (2010) Subtype classification of hepatocellular adenoma. Dig Surg 27:39\u201345. https:\/\/doi.org\/10.1159\/000268406","journal-title":"Dig Surg"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03394-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03394-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03394-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:09:36Z","timestamp":1670562576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03394-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3394"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03394-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The usage of archived diagnostic left-over tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, \u00a712,1) and by the local ethics committee (Ethics commission Hamburg, WF-049\/09). All work has been carried out in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The FABP1 antibody clone MSVA-501\u00a0M was received from MS Validated Antibodies GmbH (owned by a family member of GS).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}